Printer Friendly

FDA approves Medtronic stent to treat aortic aneurysms.

In a move that could significantly expand the market for aortic stent treatment, federal regulators have approved a stent system made by Medtronic Inc. that repairs deadly bulges in the body's largest artery.

The FDA approved the company's Talent stent system to treat aneurysms of the aorta, a vessel that delivers blood throughout the body. Aortic aneurysms lead to death in more than 15,000 people each year, according to statistics from the US Centers for Disease Control and Prevention. The affliction is the 10th leading cause of death among men older than 55.

Medtronic's Talent stent system consists of a mesh-metal tube coated in polyester that is designed to provide extra space for blood flow, reducing pressure on the aneurysm. Medtronic calls the device the "next generation version" of the Aneurx, its current aortic stent.

The FDA approved Medtronic's new stent system based on studies showing patients treated with the device had fewer complications than those who underwent traditional surgery to open the chest cavity. The Talent stent is inserted through a small incision in a patient's leg.

"The Talent Abdominal Stent Graft has provided excellent patient outcomes in clinical practice and in clinical study," said Dr. Michael L. Marin, professor of vascular surgery and chairman of the Department of Surgery at Mount Sinai Medical Center in New York, NY. "In my own experience, with more than 750 implants using the Talent system, the performance of this stent has been very consistent, and its safety and efficacy have been well characterized through the results of our own clinical trial."

COPYRIGHT 2008 Rodman Publishing
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2008 Gale, Cengage Learning. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Top of the News
Publication:Medical Product Outsourcing
Date:May 1, 2008
Words:260
Previous Article:April records series of device industry mergers.
Next Article:Given Imaging and Olympus settle patent case.
Topics:


Related Articles
ENDOLOGIX'S ELG PROMISING FOR ABDOMINAL AORTIC ANEURYSMS.
FDA APPROVES MEDTRONIC BRIDGE EXTRA SUPPORT BALLOON STENT.
Edwards sues Medtronic, Cook and Gore for patent infringement.
FDA APPROVES CORDIS DEVICES TO TREAT CLOGGED NECK ARTERIES.
Techniques using endovascular repair of major vascular pathology are advancing rapidly.
FDA PANEL TO REVIEW MEDTRONIC'S ENDEAVOR DRUG ELUTING STENT.
FDA advisory panel gives endeavor stent thumbs up.
Endovascular treatment of aortic lesions using the Medtronic [r]Talent system: single center experience with mid-term follow-up/Aortik lezyonlarin...

Terms of use | Copyright © 2014 Farlex, Inc. | Feedback | For webmasters